These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient. Aruna AS; Murungi JH Ann Pharmacother; 2005 Jun; 39(6):1131-5. PubMed ID: 15840734 [TBL] [Abstract][Full Text] [Related]
26. [Neuroleptic malignant syndrome. Case reports]. Berardi D; Troia M; Veronesi L; Ferrari G Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943 [TBL] [Abstract][Full Text] [Related]
27. Neuroleptic malignant syndrome: two cases without muscle rigidity. Wong MM Aust N Z J Psychiatry; 1996 Jun; 30(3):415-8. PubMed ID: 8839955 [TBL] [Abstract][Full Text] [Related]
28. Sympathoadrenomedullary hyperactivity in the neuroleptic malignant syndrome: a case report. Feibel JH; Schiffer RB Am J Psychiatry; 1981 Aug; 138(8):1115-6. PubMed ID: 6114644 [TBL] [Abstract][Full Text] [Related]
29. The diagnosis of neuroleptic malignant syndrome revisited. Sachdev P Aust N Z J Psychiatry; 1996 Dec; 30(6):875-6. PubMed ID: 9034484 [No Abstract] [Full Text] [Related]
30. Neuroleptic malignant syndrome due to depot fluphenazine. Grunhaus L; Sancovici S; Rimon R J Clin Psychiatry; 1979 Feb; 40(2):99-100. PubMed ID: 762037 [TBL] [Abstract][Full Text] [Related]
31. Unusual complications of antipsychotic drugs. Diamond JM; Santos AB Am Fam Physician; 1982 Oct; 26(4):153-7. PubMed ID: 6127024 [TBL] [Abstract][Full Text] [Related]
32. [Early diagnosis of the adverse effects of anti-epileptic preparations]. Vaĭntrub MIa Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(8):1231-5. PubMed ID: 696114 [No Abstract] [Full Text] [Related]
33. [Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome: a case report]. Terlikowska M; Marzański M Psychiatr Pol; 1995; 29(3):343-8. PubMed ID: 7652087 [TBL] [Abstract][Full Text] [Related]
34. The neuroleptic malignant syndrome: presentation and treatment. Birkhimer LJ; DeVane CL Drug Intell Clin Pharm; 1984 Jun; 18(6):462-5. PubMed ID: 6145570 [TBL] [Abstract][Full Text] [Related]
35. Malignant neuroleptic syndrome due to haloperidol. (A case report). Samar RK; Kaushik SK; Garg AR J Postgrad Med; 1983 Jan; 29(1):56-8. PubMed ID: 6864584 [No Abstract] [Full Text] [Related]
36. Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases. Goulon M; de Rohan-Chabot P; Elkharrat D; Gajdos P; Bismuth C; Conso F Neurology; 1983 Apr; 33(4):516-8. PubMed ID: 6682201 [TBL] [Abstract][Full Text] [Related]
37. Neuroleptic malignant syndrome related to use of clozapine. Trayer JS; Fidler DC J Am Osteopath Assoc; 1998 Mar; 98(3):168-9. PubMed ID: 9558834 [TBL] [Abstract][Full Text] [Related]
38. Lithium and neuroleptics in combination: the spectrum of neurotoxicity [corrected]. Goldman SA Psychopharmacol Bull; 1996; 32(3):299-309. PubMed ID: 8961772 [TBL] [Abstract][Full Text] [Related]